» Articles » PMID: 35497400

Accuracy of Perceived Breast Cancer Risk in Black and White Women with an Elevated Risk

Overview
Journal Ethn Dis
Date 2022 May 2
PMID 35497400
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Perceived breast cancer risk predicts screening behaviors. However, perceived risk is often inaccurate, notably in Black women, who often underestimate their risk despite having higher disease-specific mortality rates. We examined predictors of perceived breast cancer risk, and its impact on surveillance.

Methods: We used baseline data from a randomized trial targeting unaffected women recruited by relatives with early-onset breast cancer. Data collection occurred between 2012 and 2013. Accuracy of perceived risk was assessed by comparing perceived risk to objective lifetime breast cancer risks, calculated with the Gail and Claus models. A multivariate mixed model regression examined predictors of accuracy of perceived risk. The impact of perceived risk on breast cancer surveillance was assessed with one-way ANOVAS comparing Black to White women.

Results: Among participants, 21.4% self-identified as Black and 78.6% as White. Overall, 72.9% (n=247/339), 16.2% (n=55/339), and 10.9% (n=37/339) of participants overestimated, accurately perceived, and underestimated, respectively, their lifetime breast cancer risk. Race did not predict the accuracy of risk perception. Younger participants were more likely to overestimate their risk (=-.455; CI [-.772, -.138]; P=.005). MRI utilization was predicted by a higher objective risk (F 1,263 [= 30.271]; P<.001) and more accurate risk perception (P=.010; Fisher's exact test).

Conclusions: Most women with a family history of early-onset breast cancer inaccurately perceived their risk for developing the disease. Younger women were more likely to overestimate their risk. Findings can guide the development of tailored interventions to improve adherence to breast cancer surveillance recommendations.

Citing Articles

Barriers and facilitators to breast cancer screening among high-risk women: a qualitative study.

Conley C, Anderson A, Rodriguez J, Kang H, Taylor E, Luck C Breast Cancer Res Treat. 2024; 209(1):61-71.

PMID: 39190231 PMC: 11786993. DOI: 10.1007/s10549-024-07471-y.


Breast cancer screening patterns and associated factors in Iranian women over 40 years.

Seyedkanani E, Hosseinzadeh M, Mirghafourvand M, Sheikhnezhad L Sci Rep. 2024; 14(1):15274.

PMID: 38961238 PMC: 11222508. DOI: 10.1038/s41598-024-66342-0.


Participation in a High-Risk Program Is Associated with a Diagnosis of Earlier-Stage Disease Among Women at Increased Risk for Breast Cancer Development.

Pilewskie M, Eroglu I, Sevilimedu V, Le T, Mangino D, Morrow M Ann Surg Oncol. 2024; 31(10):6764-6773.

PMID: 38949720 PMC: 11605954. DOI: 10.1245/s10434-024-15633-x.


Validating a model for predicting breast cancer and nonbreast cancer death in women aged 55 years and older.

Wolfson E, Schonberg M, Eliassen A, Bertrand K, Shvetsov Y, Rosner B J Natl Cancer Inst. 2023; 116(1):81-96.

PMID: 37676833 PMC: 10777669. DOI: 10.1093/jnci/djad188.


Genetic counseling and testing for females at elevated risk for breast cancer: Protocol for the randomized controlled trial of the Know Your Risk intervention.

Sweet K, Reiter P, Schnell P, Senter L, Shane-Carson K, Aeilts A Contemp Clin Trials. 2023; 133:107323.

PMID: 37661005 PMC: 10591709. DOI: 10.1016/j.cct.2023.107323.


References
1.
Cohen M . First-degree relatives of breast-cancer patients: cognitive perceptions, coping, and adherence to breast self-examination. Behav Med. 2002; 28(1):15-22. DOI: 10.1080/08964280209596394. View

2.
Killelea B, Lannin D, Horvath L, Horowitz N, Chagpar A . Factors associated with breast MRI use: a population-based analysis. Ann Surg Oncol. 2012; 20(6):1798-805. DOI: 10.1245/s10434-012-2758-8. View

3.
Wernli K, DeMartini W, Ichikawa L, Lehman C, Onega T, Kerlikowske K . Patterns of breast magnetic resonance imaging use in community practice. JAMA Intern Med. 2013; 174(1):125-32. PMC: 3905972. DOI: 10.1001/jamainternmed.2013.11963. View

4.
Gail M, Costantino J . Validating and improving models for projecting the absolute risk of breast cancer. J Natl Cancer Inst. 2001; 93(5):334-5. DOI: 10.1093/jnci/93.5.334. View

5.
Gunn C, Bokhour B, Parker V, Battaglia T, Parker P, Fagerlin A . Understanding Decision Making about Breast Cancer Prevention in Action: The Intersection of Perceived Risk, Perceived Control, and Social Context: NRG Oncology/NSABP DMP-1. Med Decis Making. 2019; 39(3):217-227. PMC: 6538065. DOI: 10.1177/0272989X19827258. View